C10009133 / invoice 10000
Species:CANINE
Breed:Cavoodle
Age (years):9
Diagnosis or signs:Humane euthanasia
Consult notes
Weight (Kg):7.10 History:History: • Presented for an end-of-life discussion. • Chronic history of gastrointestinal disease and liver disease managed with long-term corticosteroids. • Acute decompensation began approximately 2.5 weeks ago (c. Feb 23, 2026) with the owner noting the sudden onset of icterus. • Multiple recent hospitalizations at an emergency centre (ARH). • During hospitalization, the patient had a reaction to a plasma transfusion and subsequently received a blood transfusion. A liver biopsy was also performed. • Significant recent weight loss noted by the owner. • Inappetence for the past two days. • Marked decrease in mobility; unable to jump onto furniture. • Owner has observed some circling behaviour at home. Physical Examination: Unless otherwise stated - examination normal Weight: 8.7 kg MM and CRT: Icteric mucous membranes HR and rhythm: Abdominal palpation: Ears/Eyes/Nose: Marked scleral icterus Mouth/Dental: Skin and Coat: Generalized icterus evident on the skin Limbs/gait: Ambulatory but weak Other: Severe generalized muscle atrophy, particularly over the back Other Relevant Clinical Findings: • The owner reports the patient has been on numerous oral medications (10 pills per day) which have been difficult to administer. Pathology Testing: • Liver biopsy (histopathology from ARH): Results consistent with granulomatous hepatitis with marked bridging fibrosis. Assessment/Summary : • End-stage liver failure secondary to chronic granulomatous hepatitis and fibrosis, likely exacerbated by long-term corticosteroid use. • Presenting with severe hyperbilirubinemia (icterus), coagulopathy, cachexia, and anorexia. • Suspected early signs of hepatic encephalopathy (circling). • Quality of life is considered poor with a grave prognosis. Plan and Treatments: • After discussion with the owners, the decision was made for humane euthanasia. • Sedated with 0.5 mL zolazepam/tiletamine (Zolitel) administered intramuscularly. • Euthanized with 3 mL pentobarbital administered intravenously. The process was reported as quick and peaceful. • Owners have elected for private cremation with ashes to be returned in a scatter box. • Paw prints are to be made for the owners. Need for a recheck and if so, when? • Not applicable. DH
Previous claim history (11)
| Date | Claim # | Diagnosis |
|---|---|---|
| 2026-02-26 | C09974339 | HEPATOPATHY (LIVER DISORDER) |
| 2026-02-22 | C09949141 | HEPATOPATHY (LIVER DISORDER) |
| 2026-01-29 | C09825549 | HEART (CARDIAC) DISEASE |
| 2026-01-20 | C09788202 | INFLAMMATORY BOWEL DISEASE (IBD) |
| 2026-01-20 | C09788202 | OPHTHALMIC (EYE) ABNORMALITY - PRESENTING COMPLAINT |
| 2026-01-10 | C09738069 | OPHTHALMIC (EYE) ABNORMALITY - PRESENTING COMPLAINT |
| 2026-01-10 | C09781349 | INFLAMMATORY BOWEL DISEASE (IBD) |
| 2026-01-02 | C09702752 | OPHTHALMIC (EYE) ABNORMALITY - PRESENTING COMPLAINT |
| 2025-12-18 | C09648752 | INFLAMMATORY BOWEL DISEASE (IBD) |
| 2025-12-16 | C09640515 | INFLAMMATORY BOWEL DISEASE (IBD) |
| 2025-12-11 | C09622248 | INFLAMMATORY BOWEL DISEASE (IBD) |
Line items(lines with upstream diagnosis are skipped by the model)
| Line | tstarc | Amount | Date | Upstream diagnosis |
|---|---|---|---|---|
| 10000 | tstarc_consultation | 115.00 | 2026-03-10 | — |
| 20000 | tstarc_euthanasia | 210.00 | 2026-03-10 | — |
| 30000 | tstarc_afterlife_care | 380.00 | 2026-03-10 | upstreamDSTP_routine_care_-_afterlife_care |
UPM+
- DG02244HEPATOPATHY (LIVER DISORDER)DSTP_liver_disorder
- DG02942CREMATION/BURIALDSTP_routine_care_-_afterlife_care
Variant (sleepy_king)
HEPATOPATHY (LIVER DISORDER)
DSTP_liver_disorder
Conf: 0.720
Threshold: 0.26
Above: ✓
Correct?